Basics Crinetics Pharmaceuticals, Inc. IPO Date: July 16, 2018 Sector: Healthcare Industry: Biotech Market Cap: $2.76B Activated in VL: True Average Daily Range Avg Daily Range: $0.66 | 2.72% Avg Daily Range (30 D): $0.69 | 2.18% Avg Daily Range (90 D): $0.80 | 2.41% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .72M Avg Daily Volume (90 D): .81M Trade Size Avg Trade Size (Sh.): 64 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 57 Institutional Trades Total Inst.Trades: 2,261 Avg Inst. Trade: $2.38M Avg Inst. Trade (30 D): $2.41M Avg Inst. Trade (90 D): $2.47M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.66M Avg Closing Trade (30 D): $3.98M Avg Closing Trade (90 D): $4.85M Avg Closing Volume: 107.71K         News May 23, 2025 @ 12:00 PM Crinetics Pharmaceuticals to Participate in the Je... Source: N/A Feb 6, 2025 @ 9:35 PM Crinetics Pharmaceuticals to Report Fourth Quarter... Source: N/A Jan 10, 2025 @ 12:00 PM Crinetics Announces Positive Topline Results From ... Source: N/A Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight Dec 16, 2024 @ 2:10 PM Neurocrine's Drug Gains FDA Nod As First Targeted ... Source: Vandana Singh Financials   TTM Q1 2025 Q3 2024 Basic EPS $-1.04 $-.96 Diluted EPS $-1.04 $-.96 Revenue $ $ .36M $ M Gross Profit $ $ $ Net Income / Loss $ $ -96.77M $ -76.83M Operating Income / Loss $ $ -111.41M $ -87.8M Cost of Revenue $ $ $ Net Cash Flow $ $ -169.98M $ 15.11M PE Ratio